Vaxcyte
PCVX
55.39
-2.97
-5.09%
Vaxcyte
US · PCVX
#1630 by market cap
Listed 2020
55.39
-2.97
-5.09%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Vaxcyte
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
- Founded
- 2013
- CEO
- Mr. Grant E. Pickering
- Employees
- 507
- Headquarters
- San Carlos, California, United States of America
- Fiscal year end
- 12-31
- Website
- vaxcyte.com
Company profile
- Exchange
- US
- Symbol
- PCVX
- Market-cap rank
- #1630
- Listing date
- 2020-06-12
- Market cap
- 8.77B
- Float cap
- 8.08B
- Shares out
- 158.30M
- Float shares
- 145.89M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Vaxcyte discussion 0 comments